FMR LLC - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 109 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,832,839
-76.5%
2,700,727
-38.2%
0.00%
-50.0%
Q2 2023$29,127,157
-81.8%
4,373,447
-48.9%
0.00%
-71.4%
Q1 2023$159,606,182
+76.8%
8,553,386
+103.5%
0.01%
-22.2%
Q4 2022$90,289,806
+82.0%
4,203,436
+0.1%
0.01%
+80.0%
Q3 2022$49,616,000
-10.4%
4,197,625
+0.0%
0.01%
-16.7%
Q2 2022$55,405,000
-36.9%
4,197,356
+0.0%
0.01%
-14.3%
Q1 2022$87,766,000
+2.9%
4,197,324
+0.0%
0.01%
+16.7%
Q4 2021$85,326,000
-25.7%
4,197,049
+10.9%
0.01%
-33.3%
Q3 2021$114,887,000
+26.9%
3,785,384
+21.5%
0.01%
+28.6%
Q2 2021$90,516,000
-5.9%
3,114,813
+39.7%
0.01%
-12.5%
Q1 2021$96,241,000
+4.1%
2,229,843
+11.4%
0.01%0.0%
Q4 2020$92,492,000
+10.7%
2,001,988
+3.9%
0.01%0.0%
Q3 2020$83,538,000
+842.0%
1,926,620
+1051.7%
0.01%
+700.0%
Q2 2020$8,868,000
-34.5%
167,290
-72.4%
0.00%
-50.0%
Q1 2020$13,533,000
+1.7%
605,490
-33.5%
0.00%
+100.0%
Q4 2019$13,304,000
+107.5%
910,5890.0%0.00%0.0%
Q3 2019$6,411,000
-17.2%
910,589
+28.8%
0.00%0.0%
Q2 2019$7,746,000
-6.9%
706,789
-16.0%
0.00%0.0%
Q1 2019$8,320,000
+150.3%
841,245
-2.3%
0.00%
Q4 2018$3,324,000
-67.1%
861,135
-34.7%
0.00%
-100.0%
Q3 2018$10,098,000
-34.1%
1,318,342
-20.9%
0.00%
-50.0%
Q2 2018$15,333,000
-10.2%
1,666,6660.0%0.00%0.0%
Q1 2018$17,067,0001,666,6660.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 40,000$836,0001.01%
ACT CAPITAL MANAGEMENT, LLC 20,000$418,0000.44%
Knoll Capital Management, LLC 20,000$418,0000.26%
Artemis Investment Management LLP 1,428,228$29,855,0000.24%
Rubric Capital Management LP 268,528$5,615,0000.20%
Virtus ETF Advisers LLC 7,713$161,0000.07%
BOOTHBAY FUND MANAGEMENT, LLC 107,700$2,252,0000.05%
PDT Partners, LLC 28,031$586,0000.05%
AllSquare Wealth Management LLC 3,162$66,0000.04%
Hennion & Walsh Asset Management, Inc. 35,221$736,0000.04%
View complete list of BIOXCEL THERAPEUTICS INC shareholders